当前位置:首页 - 行情中心 - 奥精医疗(688613) - 财务分析 - 现金流量表

奥精医疗

(688613)

  

流通市值:22.78亿  总市值:22.78亿
流通股本:1.37亿   总股本:1.37亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金41,563,608.49296,058,328.29189,844,695.76134,873,470.31
  收到的税费返还114,890.243,209,435.27919,556.99259,848.14
  收到其他与经营活动有关的现金237,836.325,254,626.618,890,227.278,669,590.93
  经营活动现金流入小计41,916,335.05304,522,390.17199,654,480.02143,802,909.38
  购买商品、接受劳务支付的现金20,228,453.3796,295,788.473,123,632.9461,919,364.88
  支付给职工以及为职工支付的现金27,861,385.1479,131,046.9163,908,717.845,457,485.36
  支付的各项税费11,349,187.2428,593,037.1423,077,450.9216,840,756.68
  支付其他与经营活动有关的现金13,651,980.3861,010,663.3344,041,770.8923,823,460.68
  经营活动现金流出小计73,091,006.13265,030,535.78204,151,572.55148,041,067.6
  经营活动产生的现金流量净额平衡项目0.01000
  经营活动产生的现金流量净额-31,174,671.0739,491,854.39-4,497,092.53-4,238,158.22
二、投资活动产生的现金流量:
  收回投资收到的现金-25,000,00025,000,00013,000,000
  取得投资收益收到的现金-124,271.6439,774.4815,855.8
  处置固定资产、无形资产和其他长期资产收回的现金净额90357227152
  投资活动现金流入小计9025,124,628.6425,040,001.4813,016,007.8
  购建固定资产、无形资产和其他长期资产支付的现金1,214,756.5628,927,434.2317,968,305.548,552,469.96
  投资支付的现金-30,000,00030,000,00020,000,000
  投资活动现金流出小计1,214,756.5658,927,434.2347,968,305.5428,552,469.96
  投资活动产生的现金流量净额-1,214,666.56-33,802,805.59-22,928,304.06-15,536,462.16
三、筹资活动产生的现金流量:
  吸收投资收到的现金-14,705,486.4314,705,486.4314,705,486.43
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-14,705,486.4314,705,486.4314,705,486.43
  偿还债务支付的现金32,860,0004,692,173.333,692,173.332,300,000
  分配股利、利润或偿付利息支付的现金266,315.562,280,433.191,745,187.621,181,869.43
  支付其他与筹资活动有关的现金230,355.41,468,052.911,023,898.281,023,898.28
  筹资活动现金流出小计33,356,670.968,440,659.436,461,259.234,505,767.71
  筹资活动产生的现金流量净额-33,356,670.966,264,8278,244,227.210,199,718.72
四、汇率变动对现金及现金等价物的影响-23,176.06395,521.51409,595.3280,778.77
五、现金及现金等价物净增加额-65,769,184.6512,349,397.31-18,771,574.09-9,294,122.89
  加:期初现金及现金等价物余额169,063,830.02156,714,432.71156,714,432.71156,714,432.71
  期末现金及现金等价物余额103,294,645.37169,063,830.02137,942,858.62147,420,309.82
补充资料:
  净利润-9,502,355-5,536,353.97
  资产减值准备-161,868.18--
  固定资产和投资性房地产折旧-18,291,281.65-7,813,777.36
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-18,291,281.65-7,813,777.36
  无形资产摊销-1,926,510.45-1,012,669.3
  长期待摊费用摊销-9,431,337.27-4,166,629.93
  处置固定资产、无形资产和其他长期资产的损失--464,678.56--170,568.35
  公允价值变动损失--13,054,629.26--6,907,221.52
  财务费用-2,381,895.43-1,230,683.18
  投资损失--124,271.64--15,855.8
  递延所得税-3,686,317.85-0
  其中:递延所得税资产减少-1,151,125.13--
    递延所得税负债增加-2,535,192.72--
  存货的减少--22,239,720.6--41,892,368.95
  经营性应收项目的减少-29,991,126.62-18,705,686.12
  经营性应付项目的增加-2,806,085.75-9,064,095.85
  现金的期末余额-169,063,830.02-147,420,309.82
  减:现金的期初余额-156,714,432.71-156,714,432.71
  现金及现金等价物的净增加额-12,349,397.31--9,294,122.89
公告日期2026-04-292026-04-292025-10-302025-08-30
审计意见(境内)标准无保留意见
TOP↑